A new twist on a DNA-tweaking technology may help scientists hit cancer where it hurts.
Damaging tiny parts of cancer cells’ machinery can pinpoint potential Achilles’ heels, researchers suggest May 11 in Nature Biotechnology. These vulnerable spots may be good places to aim drugs, says study coauthor Christopher Vakoc, a molecular biologist at Cold Spring Harbor Laboratory in New York.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.